Public health practitioners should use this guidance to respond to laboratory reports or clinical notifications of infection with STEC, including O157 and non-O157 serogroups.
The guidance is accompanied by:
- template letters
- algorithms for local response to cases of infection
- risk assessment proforma
- leaflets for cases
The guidance should be used along with the national surveillance questionnaire.